Buy Editas Medicine Stock | EDIT Stock Price & Latest News | Public.com
EDIT

Editas Medicine

$0.00 (0.00%)Today
    View Editas Medicine (EDIT) stock trends here

    About EDIT

    Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhan...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.13
    -0.25
    -0.63
    -1
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.79

    Actual EPS
    Q2 2021

    Stats

    Market Cap$2,33B
    Volume2
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$99.95
    1 Year Low$21.41
    Open$38.17
    High$39.22
    Low$33.58

    Buy any stock with any amount of money.

    Download the App
    Download the app